Digitized validation of ECG criteria for left ventricular hypertrophy: an elite athlete CMR study

25 April 2024 (09:00 - 12:30)

Organised by:

Sign in to view the resources

Sign in to view the resources

About the speaker

Mr Maarten Van Diepen

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

10 More presentations in this session

Presentation thumbnail

Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy

Doctor C. Nie (Beijing, CN)

Abstract Slides

Presentation thumbnail

Are patients with hypertrophic cardiomyopathy given appropriate advice on exercise at a central London inherited cardiac conditions outpatient service?

Doctor K. Sonthikaew (Bangkok, TH)

Abstract Slides

Presentation thumbnail

Cardiac magnetic resonance imaging aids in differentiating dilated cardiomyopathy from the athlete's heart

Mr J. Daems (Amsterdam, NL)

Abstract Slides

Presentation thumbnail

Optimising screening of intermediate to high-risk asymptomatic sportsmen with exercise electrocardiogram.

Doctor D. Hupin (Saint-Etienne, FR)

Abstract Slides

Presentation thumbnail

Cardiopulmonary exercise testing in athletes and non-athletes with hypertrophic cardiomyopathy

Doctor J. Scicluna (Msida, MT)

Abstract Slides

Access the full session

Session thumbnail

Hypertrophic cardiomyopathy: diagnosis and management

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024

You may be interested in

Congress Session

How to prescribe exercise for people with valvular heart disease or hypertension

Congress Presentation

Pre-participation cardiac screening: how can it help?

Congress Presentation

Paediatric sports cardiology: a much needed specialty requiring its own guidelines?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources